Infants and children aged 2 months to 18 years. Target populations include children with mild to severe cognitive impairments, developmental delay, and cerebral palsy.
Infants and children aged 2 months to 18 years. Target populations include children with mild to severe cognitive impairments, developmental delay, and cerebral palsy.